1-16023628-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004070.4(CLCNKA):​c.101-172C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.592 in 152,060 control chromosomes in the GnomAD database, including 27,345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 27345 hom., cov: 32)

Consequence

CLCNKA
NM_004070.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.497

Publications

4 publications found
Variant links:
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CLCNKA Gene-Disease associations (from GenCC):
  • Bartter disease type 4B
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 1-16023628-C-G is Benign according to our data. Variant chr1-16023628-C-G is described in ClinVar as [Benign]. Clinvar id is 1250545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.759 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKANM_004070.4 linkc.101-172C>G intron_variant Intron 2 of 19 ENST00000331433.5 NP_004061.3 P51800-1
CLCNKANM_001042704.2 linkc.101-172C>G intron_variant Intron 2 of 19 NP_001036169.1 P51800-3
CLCNKANM_001257139.2 linkc.101-172C>G intron_variant Intron 2 of 18 NP_001244068.1 P51800-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKAENST00000331433.5 linkc.101-172C>G intron_variant Intron 2 of 19 1 NM_004070.4 ENSP00000332771.4 P51800-1

Frequencies

GnomAD3 genomes
AF:
0.592
AC:
89938
AN:
151942
Hom.:
27318
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.703
Gnomad AMI
AF:
0.380
Gnomad AMR
AF:
0.472
Gnomad ASJ
AF:
0.460
Gnomad EAS
AF:
0.779
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.511
Gnomad MID
AF:
0.634
Gnomad NFE
AF:
0.560
Gnomad OTH
AF:
0.601
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.592
AC:
90004
AN:
152060
Hom.:
27345
Cov.:
32
AF XY:
0.585
AC XY:
43453
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.703
AC:
29185
AN:
41498
American (AMR)
AF:
0.471
AC:
7206
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.460
AC:
1597
AN:
3468
East Asian (EAS)
AF:
0.779
AC:
4018
AN:
5158
South Asian (SAS)
AF:
0.571
AC:
2748
AN:
4816
European-Finnish (FIN)
AF:
0.511
AC:
5402
AN:
10574
Middle Eastern (MID)
AF:
0.634
AC:
185
AN:
292
European-Non Finnish (NFE)
AF:
0.560
AC:
38052
AN:
67942
Other (OTH)
AF:
0.599
AC:
1266
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1810
3620
5430
7240
9050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.576
Hom.:
3028
Bravo
AF:
0.591
Asia WGS
AF:
0.632
AC:
2198
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.19
DANN
Benign
0.55
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2017577; hg19: chr1-16350123; COSMIC: COSV58890901; COSMIC: COSV58890901; API